Varied histomorphology and clinical outcomes of FGFR3-TACC3 fusion gliomas

Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review

(2022) Giuseppe Broggi et al.   Frontiers in Neurology

Can adult IDH-wildtype glioblastomas with FGFR3:TACC3 fusions be reliably predicted by histological features?

(2021) Ahmed Gilani et al.   CLINICAL NEUROPATHOLOGY

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3 ‐ TACC3 Fusion and Recurrent Glioblastoma

(2020) Yong Wang et al.   ONCOLOGIST

Fierce-21: Phase II study of vofatmab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC).

(2019) Andrea Necchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Recurrent Papillary Glioneuronal Tumor

(2019) Eric A. Goethe et al.   World Neurosurgery

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

(2019) Yohann Loriot et al.   NEW ENGLAND JOURNAL OF MEDICINE

OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study

(2019) A B Lassman et al.   NEURO-ONCOLOGY

A metabolic function of FGFR3-TACC3 gene fusions in cancer

(2018) Véronique Frattini et al.   NATURE

CD34 Expression in Low-Grade Epilepsy-Associated Tumors: Relationships with Clinicopathologic Features

(2018) Marco Giulioni et al.   World Neurosurgery

Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures

(2017) Adrienne Johnson et al.   ONCOLOGIST

Surgical Resection and Cellular Proliferation Index Predict Prognosis for Patients with Papillary Glioneuronal Tumor: Systematic Review and Pooled Analysis

(2017) Abdul-Kareem Ahmed et al.   World Neurosurgery

Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway

(2016) Jason T. Huse et al.   ACTA NEUROPATHOLOGICA

Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy

(2016) Mohamed A. M. Ali   Molecular Diagnosis & Therapy

Clonal evolution of glioblastoma under therapy

(2016) Jiguang Wang et al.   NATURE GENETICS

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma

(2015) A. L. Di Stefano et al.   CLINICAL CANCER RESEARCH

Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma

(2012) D. Singh et al.   SCIENCE

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

(2010) David E. Gerber et al.   CANCER CELL